Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Phase 1, Open-Label Evaluation Of The Effect Of PF-00547659 (Anti Madcam Monoclonal Antibody) On Cerebrospinal Fluid (CSF) Lymphocytes In Volunteers With Crohns Disease Or Ulcerative Colitis Who Are Anti-TNFInadequate Responders (TOSCA)

NCT01387594 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01387594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01387594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Phase 1, Open-Label Evaluation Of The Effect Of PF-00547659 (Anti Madcam Monoclonal Antibody) On Cerebrospinal Fluid (CSF) Lymphocytes In Volunteers With Crohns Disease Or Ulcerative Colitis Who Are Anti-TNFInadequate Responders (TOSCA)
Lead sponsor
Shire
Phase
Phase 1
Overall status
Completed
Start date
May 3, 2012
Completion date
November 26, 2015
Enrollment
49 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, granulomatous colitis, ileitis, ileo-colonic and colonic crohn's disease, regional enteritis, ulcerative colitis